These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 12507274)
1. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil. Yamashita Y; Yamane K; Fujikawa R; Okubo M; Kohno N Endocr J; 2002 Oct; 49(5):555-9. PubMed ID: 12507274 [TBL] [Abstract][Full Text] [Related]
2. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496 [TBL] [Abstract][Full Text] [Related]
3. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant. Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533 [TBL] [Abstract][Full Text] [Related]
4. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Wada N; Mukai M; Kohno M; Notoya A; Ito T; Yoshioka N Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan. Huang CN; Hsu TC; Chou HH; Tsay GJ J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822 [TBL] [Abstract][Full Text] [Related]
8. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil. Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036 [TBL] [Abstract][Full Text] [Related]
9. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease. Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240 [TBL] [Abstract][Full Text] [Related]
13. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis. Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473 [TBL] [Abstract][Full Text] [Related]
14. Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil. Fujieda M; Suzuki K; Sato H; Hattori M; Wada N; Tsuchiya M; Okamoto N; Murata T; Matsudaira M; Shimizu M; Ohta K; Naruse K; Sugihara S; Wakiguchi H Clin Nephrol; 2005 Jun; 63(6):437-45. PubMed ID: 15960145 [TBL] [Abstract][Full Text] [Related]
15. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Gao Y; Ye H; Yu F; Guo XH; Zhao MH Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262 [TBL] [Abstract][Full Text] [Related]
16. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease. Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809 [TBL] [Abstract][Full Text] [Related]
17. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody]. Ye H; Gao Y; Guo XH; Zhao MH Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836 [TBL] [Abstract][Full Text] [Related]
18. [MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy]. Fujii A; Arimura Y; Minoshima S; Kobayashi M; Yoshihara K; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Takahashi H Ryumachi; 1997 Dec; 37(6):788-93. PubMed ID: 9492566 [TBL] [Abstract][Full Text] [Related]
19. [A case of MPO-ANCA positive vasculitis associated with multiple pulmonary nodules following propylthiouracil treatment]. Shimizudani N; Senba S; Odaka T; Utsumi K; Nemoto K; Hatao H; Ito M; Adachi H; Kishi K; Oh-ishi S; Nakamura H; Matsuoka T Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):98-103. PubMed ID: 19260531 [TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China. Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]